Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Rothstein

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|August 30, 2005
Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatisMinsheng Xia, Robert J Suchland, Joli A Carswell, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureusChristopher K Murphy, Steve Mullin, Marcia S Osburne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 17, 2012
Profound depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells does not prevent graft-versus-host disease inductionHongmei Li, Anthony J Demetris, Jennifer McNiff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasisAnita L Tang, John R Teijaro, Modesta N Njau, et al.
Diabetes|March 29, 2003
Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154R Damaris Molano, Antonello Pileggi, Thierry Berney, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2014
Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cellsAravind Cherukuri, David M Rothstein, Brendan Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Cutting edge: transplantation tolerance through enhanced CTLA-4 expressionCharlotte Ariyan, Paolo Salvalaggio, Scott Fecteau, et al.
Transplantation|June 27, 2008
Central tolerance to myogenic cell transplants does not include muscle neoantigensGeoffrey Camirand, Lionel Stéphan, Joël Rousseau, et al.
The Journal of Clinical Investigation|June 5, 2002
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant toleranceKoji Kishimoto, Sigrid Sandner, Jaime Imitola, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infectionDavid M Rothstein, Ronald S Farquhar, Klari Sirokman, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|August 30, 2005
Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatisMinsheng Xia, Robert J Suchland, Joli A Carswell, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
In vitro activity of novel rifamycins against rifamycin-resistant Staphylococcus aureusChristopher K Murphy, Steve Mullin, Marcia S Osburne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 17, 2012
Profound depletion of host conventional dendritic cells, plasmacytoid dendritic cells, and B cells does not prevent graft-versus-host disease inductionHongmei Li, Anthony J Demetris, Jennifer McNiff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasisAnita L Tang, John R Teijaro, Modesta N Njau, et al.
Diabetes|March 29, 2003
Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154R Damaris Molano, Antonello Pileggi, Thierry Berney, et al.
Journal of the American Society of Nephrology : JASN|March 11, 2014
Immunologic human renal allograft injury associates with an altered IL-10/TNF-α expression ratio in regulatory B cellsAravind Cherukuri, David M Rothstein, Brendan Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Cutting edge: transplantation tolerance through enhanced CTLA-4 expressionCharlotte Ariyan, Paolo Salvalaggio, Scott Fecteau, et al.
Transplantation|June 27, 2008
Central tolerance to myogenic cell transplants does not include muscle neoantigensGeoffrey Camirand, Lionel Stéphan, Joël Rousseau, et al.
The Journal of Clinical Investigation|June 5, 2002
Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant toleranceKoji Kishimoto, Sigrid Sandner, Jaime Imitola, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus isolates in murine models of infectionDavid M Rothstein, Ronald S Farquhar, Klari Sirokman, et al.
Pageof 8